Evaluating the Effectiveness of Personalized Medicine With Software
暂无分享,去创建一个
Adam Kapelner | Zachary D. Cohen | Robert J. DeRubeis | Richard Berk | Alina Levine | Justin Bleich | R. DeRubeis | R. Berk | J. Bleich | A. Kapelner | Z. Cohen | Alina Levine
[1] R. DeRubeis,et al. Treatment Selection in Depression. , 2018, Annual review of clinical psychology.
[2] Donglin Zeng,et al. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes , 2015, Journal of the American Statistical Association.
[3] Michael Berk,et al. The new field of ‘precision psychiatry’ , 2017, BMC Medicine.
[4] Thomas A Louis,et al. Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models. , 2017, Biostatistics.
[5] Erica E M Moodie,et al. Estimating Optimal Dynamic Regimes: Correcting Bias under the Null , 2009, Scandinavian journal of statistics, theory and applications.
[6] J. Matthews,et al. Randomization in Clinical Trials: Theory and Practice; , 2003 .
[7] Zachary D. Cohen,et al. The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration , 2014, PloS one.
[8] Nathan Kallus,et al. Recursive Partitioning for Personalization using Observational Data , 2016, ICML.
[9] A. Danese,et al. Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice , 2020, Schizophrenia bulletin.
[10] G. L. Paul. Strategy of outcome research in psychotherapy. , 1967, Journal of consulting psychology.
[11] Susan A. Murphy,et al. A Generalization Error for Q-Learning , 2005, J. Mach. Learn. Res..
[12] Marc Ratkovic,et al. Estimating treatment effect heterogeneity in randomized program evaluation , 2013, 1305.5682.
[13] Mark J van der Laan,et al. Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule , 2015, Journal of causal inference.
[14] Holly Janes,et al. Combining biomarkers to optimize patient treatment recommendations , 2014, Biometrics.
[15] R. DeRubeis,et al. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. , 2009, Journal of consulting and clinical psychology.
[16] Leroy Hood,et al. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.
[17] I. Mechelen,et al. Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them , 2015, Behavior Research Methods.
[18] R. Dawes. Judgment under uncertainty: The robust beauty of improper linear models in decision making , 1979 .
[19] B. Rothbaum,et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. van Eys,et al. Interaction between prognostic factors and treatment. , 1983, Controlled clinical trials.
[21] T. Cai,et al. Identifying predictive markers for personalized treatment selection , 2016, Biometrics.
[22] R. DeRubeis,et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. , 2005, Archives of general psychiatry.
[23] A. Buja,et al. Valid post-selection inference , 2013, 1306.1059.
[24] J. Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes , Part I : Main Content , 2011 .
[25] Hansheng Wang,et al. Subgroup Analysis via Recursive Partitioning , 2009, J. Mach. Learn. Res..
[26] Wenbin Lu,et al. Variable selection for optimal treatment decision , 2013, Statistical methods in medical research.
[27] David C. Mohr,et al. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. , 2015, JAMA psychiatry.
[28] D. Byar,et al. Selecting optimal treatment in clinical trials using covariate information. , 1977, Journal of chronic diseases.
[29] D. Rubin. Estimating causal effects of treatments in randomized and nonrandomized studies. , 1974 .
[30] Erica Moodie,et al. Dynamic treatment regimes. , 2004, Clinical trials.
[31] Francesco C Stingo,et al. Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants , 2019, Biometrical journal. Biometrische Zeitschrift.
[32] Susan A. Murphy,et al. A Conceptual Framework for Adaptive Preventive Interventions , 2004, Prevention Science.
[33] Lacey Gunter,et al. Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate , 2011, Journal of biopharmaceutical statistics.
[34] R. Lalonde. Evaluating the Econometric Evaluations of Training Programs with Experimental Data , 1984 .
[35] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[36] J. Rice. Mathematical Statistics and Data Analysis , 1988 .
[37] D. Wolfe,et al. Test for qualitative interaction of clinical significance. , 1997, Statistics in medicine.
[38] A. Agresti. An introduction to categorical data analysis , 1997 .
[39] Yakovlev AYu,et al. The choice of cancer treatment based on covariate information. , 1994, Statistics in medicine.
[40] Z. Segal,et al. Personality and Differential Treatment Response in Major Depression: A Randomized Controlled Trial Comparing Cognitive-Behavioural Therapy and Pharmacotherapy , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[41] Dennis L. Sun,et al. Exact post-selection inference, with application to the lasso , 2013, 1311.6238.
[42] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[43] J. Berger,et al. A Bayesian Approach to Subgroup Identification , 2014, Journal of biopharmaceutical statistics.
[44] I NICOLETTI,et al. The Planning of Experiments , 1936, Rivista di clinica pediatrica.
[45] L. Gunter,et al. A Simple Method for Variable Selection in Regression with Respect to Treatment Selection , 2011 .
[46] Julian J. Faraway,et al. Does data splitting improve prediction? , 2013, Stat. Comput..
[47] S. Murphy,et al. An experimental design for the development of adaptive treatment strategies , 2005, Statistics in medicine.
[48] Yoshua Bengio,et al. Convolutional networks for images, speech, and time series , 1998 .
[49] D. Cox. A note on data-splitting for the evaluation of significance levels , 1975 .
[50] Erica E M Moodie,et al. Demystifying Optimal Dynamic Treatment Regimes , 2007, Biometrics.
[51] Anastasios A. Tsiatis,et al. Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes , 2012, Statistical science : a review journal of the Institute of Mathematical Statistics.
[52] M. Gail,et al. Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.
[53] J. Robins,et al. Estimation and extrapolation of optimal treatment and testing strategies , 2008, Statistics in medicine.
[54] I. van Mechelen,et al. Qualitative interaction trees: a tool to identify qualitative treatment–subgroup interactions , 2014, Statistics in medicine.
[55] Andreas Buja,et al. Using recursive partitioning to find and estimate heterogenous treatment effects in randomized clinical trials , 2018, Journal of Experimental Criminology.
[56] D. Zeng,et al. Recent development on statistical methods for personalized medicine discovery , 2013, Frontiers of Medicine.
[57] A. Franco,et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. , 2013, JAMA psychiatry.
[58] D P Byar,et al. Assessing apparent treatment--covariate interactions in randomized clinical trials. , 1985, Statistics in medicine.
[59] James M. Robins,et al. Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .
[60] Jason Brinkley,et al. A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime , 2010, Biometrics.
[61] M. Silvapulle,et al. Tests Against Qualitative Interaction: Exact Critical Values and Robust Tests , 2001, Biometrics.
[62] K. Davies. The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine , 2010 .
[63] G. Andersson,et al. PERSONALIZED TREATMENT OF ADULT DEPRESSION: MEDICATION, PSYCHOTHERAPY, OR BOTH? A SYSTEMATIC REVIEW , 2012, Depression and anxiety.
[64] A. Buja,et al. Covariance Adjustments for the Analysis of Randomized Field Experiments , 2013, Evaluation review.
[65] B. Chakraborty,et al. Statistical Methods for Dynamic Treatment Regimes: Reinforcement Learning, Causal Inference, and Personalized Medicine , 2013 .
[66] Susan Murphy,et al. Inference for non-regular parameters in optimal dynamic treatment regimes , 2010, Statistical methods in medical research.
[67] T. Shakespeare,et al. Observational Studies , 2003 .
[68] Eric B. Laber,et al. A Robust Method for Estimating Optimal Treatment Regimes , 2012, Biometrics.
[69] D. Freedman,et al. Weighting Regressions by Propensity Scores , 2008, Evaluation review.
[70] Daniel J. Lizotte,et al. Set‐valued dynamic treatment regimes for competing outcomes , 2012, Biometrics.
[71] L. Hood,et al. Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.
[72] M. J. van der Laan,et al. Statistical Issues and Limitations in Personalized Medicine Research with Clinical Trials , 2012, The international journal of biostatistics.
[73] J. Foster. Subgroup Identification and Variable Selection from Randomized Clinical Trial Data. , 2013 .
[74] Andreas Buja,et al. Misspecified Mean Function Regression , 2014 .
[75] Jessica K. Barrett,et al. Doubly Robust Estimation of Optimal Dynamic Treatment Regimes , 2014, Statistics in biosciences.
[76] Eric B. Laber,et al. Inference about the expected performance of a data-driven dynamic treatment regime , 2014, Clinical trials.
[77] George E. P. Box,et al. Empirical Model‐Building and Response Surfaces , 1988 .
[78] S. Murphy,et al. PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES. , 2011, Annals of statistics.
[79] S. Burger. An Introduction to the Study of Experimental Medicine , 1950, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.
[80] M. Kosorok,et al. Q-LEARNING WITH CENSORED DATA. , 2012, Annals of statistics.
[81] Phil Ansell,et al. Regret‐Regression for Optimal Dynamic Treatment Regimes , 2010, Biometrics.
[82] A. Buja,et al. Calibration for Simultaneity : ( Re ) Sampling Methods for Simultaneous Inference with Applications to Function Estimation and Functional Data , 2022 .
[83] M. Relling,et al. Moving towards individualized medicine with pharmacogenomics , 2004, Nature.
[84] Min Zhang,et al. Estimating optimal treatment regimes from a classification perspective , 2012, Stat.
[85] Ian W McKeague,et al. Estimation of treatment policies based on functional predictors. , 2014, Statistica Sinica.
[86] Jian-Hua Shao,et al. Bootstrap Sample Size in Nonregular Cases , 1994 .
[87] Craig A. Rolling,et al. Model selection for estimating treatment effects , 2014 .
[88] S. Murphy,et al. Optimal dynamic treatment regimes , 2003 .
[89] Marie Davidian,et al. Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. , 2013, Biometrika.
[90] Adam Kapelner,et al. A matching procedure for sequential experiments that iteratively learns which covariates improve power. , 2021, Biometrics.